Status:
COMPLETED
Asthma Control Among Patients Receiving Inhaled Corticosteroids in Thailand
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
12+ years
Brief Summary
The purpose of this study is to determine the percentage of patients who has reached the GINA guideline of asthma treatment after receiving any inhaled corticosteroid for 3 months or longer in actual ...
Eligibility Criteria
Inclusion
- Established persistent asthma
- Currently treated with any inhaled corticosteroid therapy but not SYMBICORT nor SERETIDE for 3 months or longer
Exclusion
- Currently participating or have participated in a study with an investigational compound within the last 30 days
- Current diagnosis of chronic obstructive pulmonary disease (COPD)
- Smoked more than 10 packs a year
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2009
Estimated Enrollment :
1210 Patients enrolled
Trial Details
Trial ID
NCT00800904
Start Date
May 1 2009
End Date
November 1 2009
Last Update
December 3 2010
Active Locations (26)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Amnat Charoen, Thailand
2
Research Site
Buriram, Thailand
3
Research Site
Chachoengsao, Thailand
4
Research Site
Chaiyaphum, Thailand